Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01953016 · ClinicalTrials.gov registry record
Participation in a Research Registry for Immune Disorders
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 716
- Enrollment target
NCT01953016: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT01953016 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 716 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01953016 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 716 participants
- Enrollment target
Study Summary
Background: \- People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has a network to collect data about people with PIDD. It is called the United States Immunodeficiency Network. It will help doctors and scientists better understand these disorders. The goal is to get medical data for everyone with these disorders in the U.S. and Canada. Data will be stored in a registry. Researchers can use it to study if these disorders are increasing. They can also learn how the disorders are diagnosed and treated. Objectives: \- To collect data on people with primary immune deficiency disorders. Eligibility: \- People who have a PIDD. Design: * Data can be added with no record of personal identity. * Data can be added with identity kept separate. This data will be linked to the registry by a code number. * Data for the registry includes: * Family history * Disease treatment * Disease characteristics * Medical history * Laboratory data
Primary Outcome
The Registry will provide a minimum estimate of the prevalence of each disorder in the US, a comprehensive clinical picture of each disorder, and a resource for clinical and laboratory research.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 716 participants |
| Start Date | 2013-09-30 |
| Est. Completion | 2023-07-19 |
What the finished NCT01953016 record still lists
NCT01953016 is an observational study that tracks outcomes without assigning an intervention. The registered 716 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01953016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01953016 about?
NCT01953016 is a clinical study titled "Participation in a Research Registry for Immune Disorders". Background: \- People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has a network to collect data about people with PIDD. It is called the United States Immunodeficiency Network. It w...
What is the current status of trial NCT01953016?
This trial is currently completed. The enrollment target is 716 participants. The study started on 2013-09-30. Estimated completion is 2023-07-19.
Who is sponsoring clinical trial NCT01953016?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI